India to United States: Formoterol Export Trade Route
India has recorded 237 verified shipments of Formoterol exported to United States, representing a combined trade value of $29.9M USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $126.0K USD. The leading Indian exporter is MANKIND PHARMA LIMITED, which accounts for 54% of total export value with 126 shipments worth $16.1M USD. On the buying side, LIFESTAR PHARMA LLC is the largest importer in United States with $11.3M USD in purchases. The top 3 suppliers — MANKIND PHARMA LIMITED, CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together control 93% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Formoterol corridor is one of India's established pharmaceutical export routes, with 237 shipments documented worth a combined $29.9M USD. The route is dominated by MANKIND PHARMA LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's formoterol manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $126.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with formoterol's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #1 among India's top formoterol export destinations globally.
On the import side, key buyers of Indian formoterol in United States include LIFESTAR PHARMA LLC, CIPLA USA INC UPS SUPPLY CHAIN SOLU, SUN PHARMACEUTICAL INDUSTRIES INC and 18 others. LIFESTAR PHARMA LLC is the single largest importer with 61 shipments valued at $11.3M USD.
